Breaking News Instant updates and real-time market news.

CW

Curtiss-Wright

$130.92

-2.42 (-1.81%)

19:04
08/15/18
08/15
19:04
08/15/18
19:04

Curtiss-Wright initiated with a Neutral at UBS

UBS analyst Myles Walton initiated coverage of the Aerospace & Defense sector, starting Curtiss-Wright with a Neutral rating and $140 price target.

CW Curtiss-Wright
$130.92

-2.42 (-1.81%)

06/27/18
BARD
06/27/18
NO CHANGE
Target $149
BARD
Outperform
Curtiss-Wright weakness a buying opportunity, says Baird
Baird analyst Peter Arment said the recent pullback in Curtiss-Wright was due to the weakness within industrials from the tariff blowback. He believes the fundamentals for organic growth remain intact and he sees healthy upside for the shares with improving free cash flow generation. The analyst, who said the 2018 guidance still appears to be conservative, reiterated his Outperform rating and $149 price target on Curtiss-Wright shares and added the stock as a "Fresh Pick."
07/02/18
WBLR
07/02/18
UPGRADE
WBLR
Outperform
Curtiss-Wright upgraded to Outperform from Market Perform at William Blair
William Blair analyst Nicholas Heymann upgraded Curtiss-Wright to Outperform citing an attractive valuation and "strong" fundamentals.
07/02/18
WBLR
07/02/18
UPGRADE
WBLR
Outperform
William Blair upgrades Curtiss-Wright on 'compelling' valuation
William Blair analyst Nicholas Heymann upgraded Curtiss-Wright to Outperform from Market Perform saying the valuation is "compelling" following the recent correction in the shares. Further, the analyst finds it likely that Curtiss-Wright's next China Direct order will not be disrupted by ongoing trade tariffs with China. He also sees the prospect for better understanding of the company's underlying "continued strong double-digit earnings growth" excluding one-time costs from recent acquisitions. Heymann believes a fair valuation for Curtiss-Wright is 22 times his unchanged 2019 estimated earnings per share of $6.35.
07/02/18
07/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. RPM (RPM) upgraded to Neutral from Underweight at JPMorgan with analyst Jeffrey Zekauskas saying he believes investors are now more willing to pay a higher multiple for RPM EBITDA because of new possibilities of cost reduction, changes in capital structure, or overall changes to the company given the involvement of activist Elliott Management. 2. Capital One (COF) upgraded to Outperform from Neutral at Credit Suisse with analyst Moshe Orenbuch citing improving credit quality, ahead of the industry. 3. Wells Fargo (WFC) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Betsy Graseck stating that the bank's passing the 2018 CCAR stress test removes an overhang and indicates to her that the Fed is receptive of the changes Wells is making. 4. ZTE Corp. (ZTCOY) upgraded to Buy from Underperform at Jefferies with analyst Edison Lee saying Li Zixue becoming Chairman of the Board is an important step toward meeting the conditions of the company's settlement with the U.S. 5. Curtiss-Wright (CW) upgraded to Outperform from Market Perform at William Blair with analyst Nicholas Heymann saying the valuation is "compelling" following the recent correction in the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ABBV

AbbVie

$88.70

-0.81 (-0.90%)

05:33
01/23/19
01/23
05:33
01/23/19
05:33
Initiation
AbbVie initiated  »

AbbVie assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 28

    Jan

  • 18

    May

PFE

Pfizer

$42.26

-0.26 (-0.61%)

05:31
01/23/19
01/23
05:31
01/23/19
05:31
Downgrade
Pfizer rating change  »

Pfizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 29

    Jan

  • 18

    May

XOM

Exxon Mobil

$71.89

-1.09 (-1.49%)

05:30
01/23/19
01/23
05:30
01/23/19
05:30
Hot Stocks
Exxon Mobil, REG enter joint research agreement with Clariant »

ExxonMobil and Renewable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 10

    Feb

MYL

Mylan

$28.90

-0.68 (-2.30%)

05:30
01/23/19
01/23
05:30
01/23/19
05:30
Downgrade
Mylan rating change  »

Mylan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTS

Zoetis

$84.07

-0.55 (-0.65%)

05:29
01/23/19
01/23
05:29
01/23/19
05:29
Initiation
Zoetis initiated  »

Zoetis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

MDGL

Madrigal Pharmaceuticals

$114.07

-5.76 (-4.81%)

05:28
01/23/19
01/23
05:28
01/23/19
05:28
Initiation
Madrigal Pharmaceuticals initiated  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$80.66

-2.42 (-2.91%)

05:27
01/23/19
01/23
05:27
01/23/19
05:27
Initiation
Alnylam initiated  »

Alnylam initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$31.00

-0.53 (-1.68%)

05:26
01/23/19
01/23
05:26
01/23/19
05:26
Initiation
Elanco initiated  »

Elanco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$18.75

-0.06 (-0.32%)

05:24
01/23/19
01/23
05:24
01/23/19
05:24
Upgrade
Teva rating change  »

Teva upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

LBRT

Liberty Oilfield Services

$14.90

-0.33 (-2.17%)

05:23
01/23/19
01/23
05:23
01/23/19
05:23
Hot Stocks
Liberty Oilfield Services announces additional $100M share repurchase plan »

Liberty Oilfield Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

ICPT

Intercept

$110.76

-2.56 (-2.26%)

05:22
01/23/19
01/23
05:22
01/23/19
05:22
Initiation
Intercept initiated  »

Intercept initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

LLY

Eli Lilly

$117.06

0.51 (0.44%)

05:19
01/23/19
01/23
05:19
01/23/19
05:19
Initiation
Eli Lilly initiated  »

Eli Lilly initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 13

    Feb

  • 18

    May

NKTR

Nektar

$44.74

-1.48 (-3.20%)

, BMY

Bristol-Myers

$49.71

-0.44 (-0.88%)

05:17
01/23/19
01/23
05:17
01/23/19
05:17
Recommendations
Nektar, Bristol-Myers, Pfizer analyst commentary  »

Mizuho sees…

NKTR

Nektar

$44.74

-1.48 (-3.20%)

BMY

Bristol-Myers

$49.71

-0.44 (-0.88%)

PFE

Pfizer

$42.26

-0.26 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 28

    Jan

  • 29

    Jan

  • 28

    Feb

  • 18

    May

  • 20

    May

APHA

Aphria

$7.07

0.41 (6.16%)

05:12
01/23/19
01/23
05:12
01/23/19
05:12
Hot Stocks
Aphria urges holder to take no action regarding takeover bid by Green Growth »

Aphria confirmed that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COHU

Cohu

$17.43

-0.295 (-1.66%)

05:11
01/23/19
01/23
05:11
01/23/19
05:11
Downgrade
Cohu rating change  »

Cohu downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANSS

Ansys

$160.84

-0.79 (-0.49%)

05:09
01/23/19
01/23
05:09
01/23/19
05:09
Hot Stocks
Ansys to acquire Granta Design, terms not disclosed »

ANSYS announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.50

-3.02 (-3.20%)

05:09
01/23/19
01/23
05:09
01/23/19
05:09
Downgrade
Lowe's rating change  »

Lowe's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 27

    Feb

  • 03

    Mar

ATRA

Atara Biotherapeutics

$35.47

-1.72 (-4.62%)

05:05
01/23/19
01/23
05:05
01/23/19
05:05
Initiation
Atara Biotherapeutics initiated  »

Mizuho starts Atara…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGCO

Agco

$62.76

-1.93 (-2.98%)

04:59
01/23/19
01/23
04:59
01/23/19
04:59
Downgrade
Agco rating change  »

Agco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 06

    Feb

  • 07

    Feb

LOGI

Logitech

$33.69

0.24 (0.72%)

04:57
01/23/19
01/23
04:57
01/23/19
04:57
Upgrade
Logitech rating change  »

Logitech upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNP

TEN, Ltd.

$3.30

-0.09 (-2.65%)

04:56
01/23/19
01/23
04:56
01/23/19
04:56
Downgrade
TEN, Ltd. rating change  »

TEN, Ltd. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Stephens building materials analyst to hold group dinner »

Building Materials…

HSKA

Heska

$97.20

0.46 (0.48%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
Heska management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
UBS software analyst to hold an analyst/industry conference call »

Software Analyst Jennifer…

ENLK

EnLink Midstream Partners

$13.30

-0.28 (-2.06%)

, ENLC

EnLink Midstream

$11.51

-0.24 (-2.04%)

04:55
01/23/19
01/23
04:55
01/23/19
04:55
Conference/Events
EnLink Midstream Companies to hold a special shareholder meeting »

Special Shareholder…

ENLK

EnLink Midstream Partners

$13.30

-0.28 (-2.06%)

ENLC

EnLink Midstream

$11.51

-0.24 (-2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.